Clinical Trial Detail

NCT ID NCT04015700
Title Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Washington University School of Medicine
Indications

glioblastoma multiforme

malignant glioma

Therapies

GNOS-PV01 + INO-9012

Age Groups: adult senior

Additional content available in CKB BOOST